Page last updated: 2024-10-26

valproic acid and Hypophosphatemia

valproic acid has been researched along with Hypophosphatemia in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Hypophosphatemia: A condition of an abnormally low level of PHOSPHATES in the blood.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanley, P1
Cunningham, RJ1
Lou, L1
Vog, B1
Raina, R1
Prohaska, ES1
Muzyk, AJ1
Rivelli, SK1

Other Studies

2 other studies available for valproic acid and Hypophosphatemia

ArticleYear
Muscle Weakness and Pain With Profound Hypophosphatemia: Mystery Revealed.
    Clinical pediatrics, 2015, Volume: 54, Issue:10

    Topics: Adolescent; Epilepsy; Fanconi Syndrome; Humans; Hypophosphatemia; Male; Muscle Weakness; Valproic Ac

2015
Levocarnitine-induced hypophosphatemia in a hemodialysis patient with acute valproic acid toxicity.
    The Journal of neuropsychiatry and clinical neurosciences, 2012,Winter, Volume: 24, Issue:1

    Topics: Adolescent; Anticonvulsants; Bipolar Disorder; Carnitine; Drug-Related Side Effects and Adverse Reac

2012